XILLIO UK LIMITED
Company number 14263395 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
XILLIO UK LIMITED - Analysis Report
Company Number: 14263395
Analysis Date: 2025-07-20 13:00 UTC
Financial Health Assessment for XILLIO UK LIMITED
1. Financial Health Score: D
Explanation:
Xillio UK Limited exhibits significant financial distress indicated by persistent net liabilities and negative working capital. The company’s net assets have deteriorated further to -£316,992 in 2024 from -£268,671 in 2023. This grade reflects the company's current unhealthy financial condition and risk of insolvency without corrective measures.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £112 | Negligible long-term asset base, typical for micro companies but limits collateral for borrowing. |
| Current Assets | £28,327 | Modest short-term assets; dropped significantly from £63,575 in 2023, indicating reduced liquidity. |
| Current Liabilities | £64,355 | Short-term debts due within a year; slightly increased from previous year. |
| Net Current Assets | -£36,028 | Negative working capital, meaning current liabilities exceed current assets — a symptom of cash flow strain. |
| Total Assets Less Current Liabilities | -£35,916 | Overall asset base unable to cover short-term obligations, reflecting poor liquidity. |
| Long-term Liabilities | £281,076 | Substantial debts due beyond one year, unchanged from 2023, indicating heavy financial obligations. |
| Net Assets (Shareholders’ Funds) | -£316,992 | Deeply negative equity, indicating accumulated losses and financial distress. |
3. Diagnosis
The financial vital signs reveal that Xillio UK Limited is currently in a state analogous to a patient showing clear symptoms of financial distress:
Negative Working Capital: The company’s current liabilities exceed current assets by over £36k, which signifies that it may struggle to meet short-term obligations as they fall due. This is a classic symptom of cash flow difficulties, often leading to liquidity crises.
Persistently Negative Net Assets: The shareholders’ funds are deeply negative and worsening year-on-year. This suggests accumulated losses and an ongoing erosion of the company’s financial foundation, akin to a weakening of the company’s financial "immune system."
High Long-term Debt: With over £281k in liabilities due after one year, the company carries a significant debt burden relative to its asset base. Without adequate earnings or asset backing, this is a red flag for solvency risk.
Reduced Current Assets: The sharp decline in current assets from £63,575 to £28,327 in one year signals a shrinking liquidity buffer, exacerbating the risk of cash flow shortages.
Overall, these symptoms indicate the company is in an unhealthy financial state, with a critical need to stabilize cash flows and address the equity deficit. Without intervention, the prognosis points toward worsening distress or potential insolvency.
4. Recommendations
To restore financial wellness and improve the prognosis, Xillio UK Limited should consider the following actions:
Improve Cash Flow Management:
- Accelerate collection of receivables and tighten payment terms to customers.
- Negotiate extended payment terms with suppliers to ease immediate cash outflows.
- Monitor daily cash position closely to avoid liquidity shortfalls.
Restructure Debt:
- Engage creditors to possibly refinance or reschedule long-term liabilities to reduce near-term pressure.
- Explore options for equity injection or shareholder loans to improve the capital base.
Cost Rationalization:
- Review operational expenses and reduce non-essential costs to conserve cash.
- Consider temporary reductions in overheads or headcount if feasible without harming core operations.
Enhance Financial Reporting and Forecasting:
- Develop detailed cash flow forecasts to anticipate and plan for liquidity needs.
- Implement regular financial reviews to detect early symptoms of distress.
Strategic Review:
- Evaluate business model and market positioning to identify opportunities for revenue growth or diversification.
- Consider external advisory support if needed to guide turnaround strategies.
Medical Analogy Summary
Xillio UK Limited’s financial health is akin to a patient exhibiting signs of systemic weakness — negative liquidity ("unhealthy cash flow") and deteriorating net assets ("loss of financial vitality"). Immediate intervention is required to "stabilize the patient" through cash flow management and debt restructuring, preventing further decline and paving the way for recovery.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.